Diquafosol tetrasodium is a novel ophthalmic drug used mainly for the treatment of dry eye disease. It belongs to a class of drugs known as P2Y2 receptor agonists. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Diquafosol sodium and Diquas. Its PubChem CID is 148196.
Diquafosol tetrasodium
| CAS No | 211427-08-6 |
|---|---|
| Molecular Formula | C18H22N4Na4O23P4 |
| Molecular Weight | 878.2 g/mol |
| Synonyms | tetrasodium;[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Diquafosol tetrasodium is a novel ophthalmic drug used mainly for the treatment of dry eye disease. It belongs to a class of drugs known as P2Y2 receptor agonists.
The listed CAS number is 211427-08-6.
The listed molecular formula is C18H22N4Na4O23P4.
The listed molecular weight is 878.2 g/mol.
tetrasodium;[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate.
The source lists Diquafosol sodium and Diquas.